Table 2.
Case | Therapeutic Effect | Complications | Hospital Stay (day) | Follow-up Periods (mos) | ||||
---|---|---|---|---|---|---|---|---|
Chyluria | Urine Protein | Serum TP (g/dL)/Alb (g/dL) | ||||||
Pre-Tx | Post-Tx | Pre-Tx | Post-Tx | |||||
1-1 | recurrence (5 days) | 3+ | ± | 4.8 /2.3 |
5.8 /2.8 |
none | 14 | 165 |
1-2 | disappearance | ± | − | |||||
2 | disappearance | 3+ | − | 6.0 /3.7 |
6.6 /3.8 |
none | 5 | 137 |
3 | disappearance | 4+ | − | 4.9 /3.1 |
6.8 /4.4 |
fever (grade 1) nausea (grade 1) hypotension (grade 1) |
9 | 60 |
4-1 | recurrence (4 months) | 4+ | − | 5.4 /3.2 |
5.7 /3.4 |
none | 3 | 87 |
4-2 | disappearance | 4+ | − | fever (grade 1) pain (grade 1) |
4 | |||
5 | disappearance | 1+ | − | − | − | none | 9 | 58 |
6 | disappearance | 1+ | − | − | − | pain (grade 2) | 10 | 55 |
7 | disappearance | 3+ | − | 6.4 /4.0 |
6.9 /4.1 |
pain (grade 2) | 6 | 45 |
8 | disappearance | 3+ | − | 6.4 /3.9 |
6.7 /4.0 |
none | 4 | 44 |
9 | disappearance | 3+ | − | 5.3 /3.2 |
6.0 /3.6 |
none | 4 | 12 |
Tx—treatment; mos—months.